Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Lilly Remains Attentive To Corporate Affairs; Strattera Head Nobles Named VP

Executive Summary

Lilly Strattera Product Team Leader Anne Nobles will focus her attention on public policy and communications issues as the firm's new VP-corporate affairs, effective June 1

You may also be interested in...



Lilly White House Connections On Display; Tobias To Oversee AIDS Fund

Former Lilly CEO Randall Tobias will oversee the Bush Administration's new fund to treat and prevent HIV in developing countries, President Bush announced July 2

Lilly White House Connections On Display; Tobias To Oversee AIDS Fund

Former Lilly CEO Randall Tobias will oversee the Bush Administration's new fund to treat and prevent HIV in developing countries, President Bush announced July 2

Lilly Picks Paul’s Brain: CNS Researcher To Succeed R&D Head Watanabe

Lilly R&D president-elect Steven Paul, MD, will bring an extensive background in central nervous system discovery and research to Lilly's top research position

Related Content

UsernamePublicRestriction

Register

PS041899

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel